Obesity correlates with accelerated aging. This study aims to investigate the association between the visceral adiposity index (VAI) and accelerated aging. Biological aging was evaluated by phenotypic age acceleration (PhenoAgeAccel). Utilizing data from the National Health and Nutrition Examination Survey (NHANES) conducted between 1999 and 2010, we employed weighted multivariable logistic regression models, along with subgroup analysis, to examine the association between VAI and PhenoAgeAccel. Moreover, smooth curve fitting was utilized to identify potential nonlinear association, complemented by a two-piece linear regression model to investigate threshold effects. Of the included 11,340 participants aged 20 years and older, the mean (95% CI) age was 46.569 (45.946, 47.191) years, and 49.189% were male. The mean (95% CI) VAI for all participants was 2.176 (2.114, 2.238), and the mean (95% CI) PhenoAgeAccel was -6.306 (-6.618, -5.994) years. In the fully adjusted model, each incremental unit increase of VAI was associated with a 0.312-year increase in PhenoAgeAccel (β = 0.312, 95% CI: 0.217, 0.408). This positive association was more statistically significant among individuals with cancer. Furthermore, a segmented association was observed between VAI and PhenoAgeAccel, with a turning point identified at 10.543. Below this threshold, VAI exhibited a positive correlation with PhenoAgeAccel (β = 0.617, 95% CI: 0.499, 0.735), while beyond it, the association became nonsignificant. This study demonstrated a positive association between VAI and accelerated aging within a nationally representative population. The findings suggest that controlling adiposity may exert anti-aging effects and help prevent aging-related diseases.
5 October 2024 in Aging Clinical and Experimental Research
Objective: To investigate the association between depression, accelerated biological aging, and mortality risk, and to assess whether accelerated aging mediates the relationship between major depression and mortality risk. Methods: A prospective cohort of 12,761 participants aged 20 years or older from the 2005–2010 cycle of the National Health and Nutrition Examination Survey (NHANES) was analyzed. Depression was assessed using the Patient Health Questionnaire-9 (PHQ-9), with scores of ≥ 10 indicating major depression. Accelerated biological aging was measured using phenotypic age acceleration (PhenoAgeAccel). Multivariable linear regression models and subgroup analyses were used to examine the association between depression and accelerated aging, while weighted multivariable Cox proportional hazards regression models and subgroup analyses assessed the impact of major depression on mortality risk. Mediation analysis was performed to assess whether PhenoAgeAccel mediated the relationship between major depression and mortality outcomes. Results: Among the 12,761 adults, the weighted mean age was 46.6 years, with 48.8% being male, and 6.9% experiencing major depression. The results showed a positive association between major depression and PhenoAgeAccel (β: 0.61, 95% CI: 0.06–1.16). Over a median follow-up duration of 11.3 years (interquartile range: 9.9–13.1), major depression was associated with increased all-cause mortality (HR: 1.35, 95% CI: 1.13–1.62) and cardiovascular mortality (HR: 1.73, 95% CI: 1.18–2.54). However, the relationship with cancer mortality was not statistically significant after full adjustment for confounding factors. The mediation analysis further revealed that PhenoAgeAccel accounted for 10.32% and 5.12% of the associations between major depression and all-cause mortality, and cardiovascular mortality, respectively. Conclusion: Depression is associated with accelerated aging and contributes to increased all-cause and cardiovascular mortality. Accelerated aging partially mediates the association between major depression and mortality risk. Our findings highlight the urgent need to incorporate mental health care into public health strategies to delay population aging and reduce mortality risk.
Background: Helicobacter pylori (H. pylori) infection is associated with insulin resistance and metabolic syndrome. This study investigates the association between H. pylori seropositivity and the newly proposed hemoglobin A1c/high-density lipoprotein cholesterol ratio (HbA1c/HDL-C ratio) in a nationally representative U.S. population.Methods: Data from the 1999–2000 National Health and Nutrition Examination Survey (NHANES) were analyzed. Multivariable linear regression models assessed the association between H. pylori seropositivity and the HbA1c/HDL-C ratio. Subgroup analyses were performed to evaluate the consistency of the association across different demographic and clinical strata. Generalized additive models with smoothing splines and threshold effect analysis was conducted to identify potential nonlinear relationships.Results: The cross-sectional analysis comprised 2,909 participants, including 1,254 with H. pylori seropositivity. After multivariable adjustment, a significant positive association was found between H. pylori seropositivity and the HbA1c/HDL-C ratio (β: 0.28, 95% CI: 0.13, 0.42). Subgroup analyses revealed a stronger association among non-diabetic individuals compared to diabetic individuals. A “L”-shaped relationship was observed, with an inflection point at an HbA1c/HDL-C ratio of 4.81. Below this threshold, H. pylori seropositivity was positively associated with the HbA1c/HDL-C ratio. Above this threshold, the association was no longer statistically significant.Conclusion: This study identifies a significant association between H. pylori seropositivity and the HbA1c/HDL-C ratio, suggesting that metabolic dysfunction may be linked to H. pylori infection. Future longitudinal studies are needed to establish causality and explore underlying mechanisms.
Objective: The study aims to explore the relationship between red blood cell (RBC) folate concentrations and accelerated aging.Methods: Data were derived from the National Health and Nutrition Examination Survey (NHANES) cycles of 2007–2010, including 8,944 participants aged ≥ 20 years. Phenotypic age acceleration (PhenoAgeAccel) was calculated using chronological age and 9 aging-related biomarkers. Multivariate linear regression and generalized additive models were used to analyze the relationship between RBC folate levels and PhenoAgeAccel. Smooth curve fitting was used to explore the potential non-linear relationship and threshold effect analysis was applied to examine inflection point.Results: The analysis revealed a U-shaped relationship between RBC folate levels and PhenoAgeAccel, with the inflection point at 732.9 ng/mL. The PhenoAgeAccel decreased by 0.0027 years per 1 ng/mL increase in RBC folate when RBC folate ≤ 732.9 ng/mL (β: −0.0027, 95% CI: −0.0051, −0.0002), and increased by 0.0058 years per 1 ng/mL increase in RBC folate when RBC folate > 732.9 ng/mL (β: 0.0058, 95% CI: 0.0026, 0.0090). Subgroup analysis indicated consistent associations across most demographic and health categories, except for a positive correlation in participants with cardiovascular diseases.Conclusion: There was a U-shaped association between RBC folate and accelerated aging among US adults.
This study investigated the association of Mediterranean diet (MED) adherence with chronic constipation and chronic diarrhea, using a nationally representative sample of U.S. adults. This cross‐sectional study analyzed 11,612 participants from the 2005 to 2010 National Health and Nutrition Examination Survey (NHANES). Adherence to MED was assessed through the alternative Mediterranean diet (aMED) index. Bowel habits were categorized using the Bristol Stool Form Scale (BSFS), with chronic constipation defined as BSFS types 1–2, and chronic diarrhea as types 6–7, based on the usual or most common stool type reported by participants. Multivariate logistic regression models and subgroup analyses were employed to assess associations of MED adherence with chronic constipation and chronic diarrhea. Restricted cubic spline analyses were conducted to explore potential nonlinear relationships. Higher aMED scores were associated with a lower likelihood of chronic constipation (OR: 0.82, 95% CI: 0.75, 0.89). Participants in the highest aMED category had 43% lower odds of chronic constipation compared to those in the lowest category (OR: 0.57, 95% CI: 0.43, 0.75). Subgroup analysis indicated that this association was strongest among obese individuals (BMI ≥ 30 kg/m 2 ) (OR: 0.69, 95% CI: 0.58, 0.82). No significant associations were observed between aMED scores and chronic diarrhea in the fully adjusted model. Adherence to the Mediterranean diet was significantly associated with lower prevalence of chronic constipation but showed no significant relationship with chronic diarrhea in the U.S. population. Further longitudinal research is needed to clarify causality and explore population‐specific effects.